A good starting point for biotechnology investors is to look for stocks with upcoming catalysts. These catalysts can serve as share price drivers and perhaps even attract attention from highly coveted institutional investors such as hedge funds. One stock, Biota Pharmaceuticals (BOTA), has plenty of upcoming catalysts in addition to having a strong business that seems to offer investors plenty of potential for share price appreciation.
Biota Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat a number of serious and potentially life-threatening infectious diseases. The company is particularly experienced in respiratory diseases, particularly influenza. Biota has corporate offices in Atlanta, Georgia, and research and development...
Only subscribers can access this article, which is part of the PRO research library covering 3,553 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: